M&A Deal Summary

Asterand Bioscience Acquires AdeptBio

On August 11, 2015, Asterand Bioscience acquired life science company AdeptBio

Acquisition Highlights
  • This is Asterand Bioscience’s 3rd transaction in the Life Science sector.
  • This is Asterand Bioscience’s 2nd transaction in the United States.
  • This is Asterand Bioscience’s 1st transaction in Tennessee.

M&A Deal Summary
Date 2015-08-11
Target AdeptBio
Sector Life Science
Buyer(s) Asterand Bioscience
Deal Type Add-on Acquisition

Target

AdeptBio

Memphis, Tennessee, United States
AdeptBio LLC is specializes in procurement of human tissue specimens.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Asterand Bioscience

Detroit, Michigan, United States
Category Company
Sector Life Science
DESCRIPTION

Asterand Bioscience is a provider of high quality, well characterized human tissue and human tissue-based research solutions to drug discovery scientists. Our mission is to provide human-based solutions to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.

DEAL STATS #
Overall 3 of 3
Sector (Life Science) 3 of 3
Type (Add-on Acquisition) 3 of 3
State (Tennessee) 1 of 1
Country (United States) 2 of 2
Year (2015) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-09 Stemgent - iPS Cell Business Unit

United States

iPS cell research reagent products including mRNA reprogramming kit, xeno-free culture media, and specialty chemicals for cell differentiation, and has established a world-famous, proven and trusted brand in the iPS cell field.

Sell -
Mergr

Product

Company

Legal